Vyome Holdings (HIND) Price & Analysis

Compare

617 Followers

HIND Stock Chart & Stats

$5.42

Market closed

$5.42

Day’s Range― - ―

52-Week Range$3.11 - $515.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)51.53K

Market Cap

$18.23M

Enterprise Value$10.01M

Total Cash (Recent Filing)$5.71M

Total Debt (Recent Filing)$38.61K

Price to Earnings (P/E)―

Beta1.38

Next Earnings

Mar 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-3.12

Shares Outstanding5,644,494

10 Day Avg. Volume25,885

30 Day Avg. Volume51,532

Financial Highlights & Ratios

PEG Ratio0.01

Price to Book (P/B)-36.35

Price to Sales (P/S)1.15

P/FCF Ratio-2.08

Enterprise Value/Market Cap0.55

Enterprise Value/Revenue2.39

Enterprise Value/Gross Profit3.82

Enterprise Value/Ebitda-0.73

Forecast

1Y Price Target

$15.00

Price Target Upside176.75% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)-0.45

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Clinical Trial ResultsPhase 2 study of VT1953 met primary and secondary endpoints in treating malignant fungating wounds, showing meaningful symptom improvements and a favorable safety profile that supports advancement toward a pivotal trial.

Financial And Capital StructureLow cash burn, a clean balance sheet with no debt or warrants, existing cash reserves and a $12 million at-the-market facility provide financial flexibility and extend runway into 2027 to support ongoing development.

Market OpportunityMalignant fungating wounds represent a large unmet need with no FDA-approved therapies and a potential market opportunity exceeding one billion dollars, offering significant commercial upside if VT1953 reaches the market.

Bears Say

Vyome Holdings News

Vyome’s LiveChain Signs LOI for Humanyze Note Acquisition

Vyome Holdings ( ($HIND) ) has issued an update. On December 17, 2025, Vyome Holdings, Inc., through its...

22d ago

HIND

Vyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating

Vyome Holdings, the Healthcare sector company, was revisited by a Wall Street analyst on December 8. Analyst Jason...

1M ago

HIND

Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints

Vyome Holdings (HIND) announced the final results from an investigator-initiated Phase 2 proof of concept study of VT-1953...

1M ago

HIND

Vyome Holdings Inc. Reports Post-Merger Financials

Reshape Lifesciences Inc. ( ($HIND) ) has released its Q3 earnings. Here is a breakdown of the information...

2M ago

HIND

Vyome Holdings: Buy Rating Backed by Promising Pipeline and Strategic Growth Potential

Maxim Group analyst Jason McCarthy maintained a Buy rating on Vyome Holdings yesterday and set a price target...

2M ago

HIND

Vyome Holdings files to sell 610K shares of common stock for holders

The company will not receive any of the proceeds from the sale of common stock by the selling...

2M ago

HIND

Vyome Holdings Elects Directors at Annual Meeting

An announcement from Vyome Holdings ( ($HIND) ) is now available. On October 28, 2025, Vyome Holdings, Inc....

3M ago

HIND

Vyome Holdings Acquires AI Startup Oculo, Inc.

Vyome Holdings ( ($HIND) ) has provided an announcement. On September 29, 2025, Vyome Holdings announced the acquisition...

3M ago

HIND

Vyome Holdings upgraded to Buy at Maxim on immuno-inflammatory pipeline

As previously reported, Maxim upgraded Vyome Holdings (HIND) to Buy from Hold with a $15 price target after...

3M ago

HIND

Vyome Holdings upgraded to Buy from Hold at Maxim

Maxim upgraded Vyome Holdings (HIND) to Buy from Hold with a $15 price target after taking over coverage...

3M ago

HIND

Vyome Holdings acquires MIT AI spinout Oculo Health

Vyome announced it has acquired substantially all of the assets of Oculo. Concurrent with this transaction, Vyome has...

4M ago

HIND

Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!

Earnings reports, Federal Reserve decisions, and more have the stock market on the move today. ...

4M ago

AMD

Vyome Stock (HIND) Rockets on Uveitis Study Data

Vyome stock rocketed higher on Wednesday after the company announced results of an eye treatment study. ...

4M ago

HIND

Vyome Holdings presents results from VT-1908 preclinical studies

Vyome Holdings (HIND) presented results from its preclinical studies investigating VT-1908 for treating uveitis at the recent Annual...

4M ago

HIND

HIND FAQ

What was Vyome Holdings, Inc.’s price range in the past 12 months?

Vyome Holdings, Inc. lowest stock price was $3.11 and its highest was $515.00 in the past 12 months.

What is Vyome Holdings, Inc.’s market cap?

Vyome Holdings, Inc.’s market cap is $18.23M.

When is Vyome Holdings, Inc.’s upcoming earnings report date?

Vyome Holdings, Inc.’s upcoming earnings report date is Mar 30, 2026 which is in 75 days.

How were Vyome Holdings, Inc.’s earnings last quarter?

Vyome Holdings, Inc. released its earnings results on Nov 18, 2025. The company reported -$3.12 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$3.01.

Is Vyome Holdings, Inc. overvalued?

According to Wall Street analysts Vyome Holdings, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Vyome Holdings, Inc. pay dividends?

Vyome Holdings, Inc. does not currently pay dividends.

What is Vyome Holdings, Inc.’s EPS estimate?

Vyome Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vyome Holdings, Inc. have?

Vyome Holdings, Inc. has 5,644,494 shares outstanding.

What happened to Vyome Holdings, Inc.’s price movement after its last earnings report?

Vyome Holdings, Inc. reported an EPS of -$3.12 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went up 1.844%.

Which hedge fund is a major shareholder of Vyome Holdings, Inc.?

Currently, no hedge funds are holding shares in HIND

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Vyome Holdings, Inc.

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

Vyome Holdings (HIND) Earnings & Revenues

Historic Earnings Reports

HIND Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call highlighted several positive achievements, such as revenue growth, cost reductions, improved profit margins, and strategic agreements aimed at enhancing shareholder value. However, it also acknowledged challenges, such as the contraction in revenue over the nine-month period and competition from GLP-1 pharmaceuticals. Overall, the positive aspects slightly outweigh the negative trends.View all HIND earnings summaries

HIND Stock 12 Month Forecast

Average Price Target

$15.00

▲(176.75% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","447":"$447","113.25":"$113.3","224.5":"$224.5","335.75":"$335.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$15.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,113.25,224.5,335.75,447],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.44,4.329230769230769,5.218461538461538,6.107692307692307,6.996923076923077,7.886153846153846,8.775384615384615,9.664615384615384,10.553846153846154,11.443076923076923,12.332307692307692,13.221538461538461,14.11076923076923,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.44,4.329230769230769,5.218461538461538,6.107692307692307,6.996923076923077,7.886153846153846,8.775384615384615,9.664615384615384,10.553846153846154,11.443076923076923,12.332307692307692,13.221538461538461,14.11076923076923,{"y":15,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.44,4.329230769230769,5.218461538461538,6.107692307692307,6.996923076923077,7.886153846153846,8.775384615384615,9.664615384615384,10.553846153846154,11.443076923076923,12.332307692307692,13.221538461538461,14.11076923076923,{"y":15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":446,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":377.01,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":103,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":159,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":33.9,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":17.24,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":9.72,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":9.96,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":8.54,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.05,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.94,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.44,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >